Market Tracker

06/24 5:16pm ET

Zoetis Inc (NYSE:ZTS)

46.51
Delayed Data
As of Jun 24
 -1.39 / -2.90%
Today’s Change
37.73
Today|||52-Week Range
55.38
-2.94%
Year-to-Date
ZTS Regular Dividend: ZTS will begin trading ex-dividend on 06/28/16 with a $0.095 dividend payable to shareholders of record as of 06/30/16.
7 Profitable Medical Stocks Ranked as Buys Now
Jun 21 / Zacks.com - Paid Partner Content
5 Top ROE Stocks for Improving Your Portfolio Returns
Jun 16 / Zacks.com - Paid Partner Content
Can Zoetis (ZTS) Keep the Earnings Streak Alive This Quarter?
Jun 17 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close47.90
Today’s open46.23
Day’s range46.18 - 47.36
Volume6,423,664
Average volume (3 months)4,023,085
Market cap$23.8B
Dividend yield0.82%
Data as of 4:02pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+5.26%
Earnings growth (next 5 years)+15.30%
Revenue growth (last year)-0.42%
P/E ratio61.7
Price/Sales5.05
Price/Book22.31

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-2.60-5.63%
VRTXVertex Pharmaceutica...-6.30-7.14%
ALXNAlexion Pharmaceutic...-10.58-8.56%
INCYIncyte Corp-4.68-5.73%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.44
Annual revenue (last year)$4.8B
Annual profit (last year)$339.0M
Net profit margin7.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
Florham Park, New Jersey

Forecasts